|
|
News Breaks | | | | February 5, 2013 | | 08:09 EDT |  | COV, NYX | Covidien continues relationship with NYSE Euronext
Covidien (COV) announced that Mallinckrodt intends to apply to list its ordinary shares on the New York Stock Exchange, or NYSE, to trade under the symbol MNK. As previously announced, Covidien plans to spin off its Pharmaceuticals business into Mallinckrodt, a stand-alone company, a process expected to be completed in mid-2013. "We are very pleased to continue our relationship with the NYSE and look forward to enhancing our brand image in conjunction with NYSE Euronext (NYX)," said José E. Almeida, Chairman, President and CEO. "After a careful review, we decided that Mallinckrodt should be listed on the NYSE. We recognize the value of their deep community, unique visibility opportunities and innovative market structure, and believe it is in the best interest of both companies to be aligned with the NYSE. We look forward to continuing our strong and long engagement with the world's leading global exchange." | |
|
News For COV;NYX From The Last 14 Days Check below for free stories on COV;NYX the last two weeks. |
|
|
| There are no results for COV;NYX |
|
|
|
|
|
|
